Viemed Healthcare Announces Share Repurchase Program

An announcement from Viemed Healthcare ( (VMD) ) is now available.

On June 6, 2025, Viemed Healthcare announced that its Board of Directors approved a share repurchase program, allowing the company to buy back up to 1,976,441 common shares, representing approximately 5% of the total issued and outstanding shares as of March 31, 2025. This move, effective through June 2026, is part of Viemed’s strategy to enhance shareholder value, supported by strong first-quarter results and ample liquidity, including a $55 million credit facility, while continuing to fund its growth initiatives.

The most recent analyst rating on (VMD) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on Viemed Healthcare stock, see the VMD Stock Forecast page.

Spark’s Take on VMD Stock

According to Spark, TipRanks’ AI Analyst, VMD is a Neutral.

Viemed Healthcare shows robust financial growth and strategic expansion efforts, reflected in its solid earnings call performance. However, technical indicators suggest caution due to potential short-term pressures. The company’s valuation is reasonable given its growth outlook, although improvement in free cash flow management remains crucial.

To see Spark’s full report on VMD stock, click here.

More about Viemed Healthcare

Viemed Healthcare, Inc. is a national leader in in-home, technology-enabled post-acute respiratory care in the United States. The company provides post-acute respiratory healthcare equipment and services, including non-invasive ventilators, sleep therapy, staffing, and other complementary products and services, focusing on efficient and effective in-home treatment with clinical practitioners.

Average Trading Volume: 153,922

Technical Sentiment Signal: Sell

Current Market Cap: $265.6M

Find detailed analytics on VMD stock on TipRanks’ Stock Analysis page.